396 related articles for article (PubMed ID: 22052461)
1. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.
Jin SG; Jiang Y; Qiu R; Rauch TA; Wang Y; Schackert G; Krex D; Lu Q; Pfeifer GP
Cancer Res; 2011 Dec; 71(24):7360-5. PubMed ID: 22052461
[TBL] [Abstract][Full Text] [Related]
2. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
[TBL] [Abstract][Full Text] [Related]
3. IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC.
Xu Q; Wang K; Wang L; Zhu Y; Zhou G; Xie D; Yang Q
PLoS One; 2016; 11(8):e0161261. PubMed ID: 27548812
[TBL] [Abstract][Full Text] [Related]
4. Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?
Ficz G; Gribben JG
Genomics; 2014 Nov; 104(5):352-7. PubMed ID: 25179374
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated
Ramsawhook A; Lewis L; Coyle B; Ruzov A
Clin Epigenetics; 2017; 9():18. PubMed ID: 28228863
[TBL] [Abstract][Full Text] [Related]
7. Connections between TET proteins and aberrant DNA modification in cancer.
Huang Y; Rao A
Trends Genet; 2014 Oct; 30(10):464-74. PubMed ID: 25132561
[TBL] [Abstract][Full Text] [Related]
8. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation.
Yang H; Liu Y; Bai F; Zhang JY; Ma SH; Liu J; Xu ZD; Zhu HG; Ling ZQ; Ye D; Guan KL; Xiong Y
Oncogene; 2013 Jan; 32(5):663-9. PubMed ID: 22391558
[TBL] [Abstract][Full Text] [Related]
9. Ascorbate-induced generation of 5-hydroxymethylcytosine is unaffected by varying levels of iron and 2-oxoglutarate.
Dickson KM; Gustafson CB; Young JI; Züchner S; Wang G
Biochem Biophys Res Commun; 2013 Oct; 439(4):522-7. PubMed ID: 24021282
[TBL] [Abstract][Full Text] [Related]
10. 5-Hydroxymethylcytosine: An epigenetic mark frequently deregulated in cancer.
Kroeze LI; van der Reijden BA; Jansen JH
Biochim Biophys Acta; 2015 Apr; 1855(2):144-54. PubMed ID: 25579174
[TBL] [Abstract][Full Text] [Related]
11. CDA directs metabolism of epigenetic nucleosides revealing a therapeutic window in cancer.
Zauri M; Berridge G; Thézénas ML; Pugh KM; Goldin R; Kessler BM; Kriaucionis S
Nature; 2015 Aug; 524(7563):114-8. PubMed ID: 26200337
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
Glowacka WK; Jain H; Okura M; Maimaitiming A; Mamatjan Y; Nejad R; Farooq H; Taylor MD; Aldape K; Kongkham P
Acta Neuropathol; 2018 Apr; 135(4):617-634. PubMed ID: 29428975
[TBL] [Abstract][Full Text] [Related]
13. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Chen K; Zhang J; Guo Z; Ma Q; Xu Z; Zhou Y; Xu Z; Li Z; Liu Y; Ye X; Li X; Yuan B; Ke Y; He C; Zhou L; Liu J; Ci W
Cell Res; 2016 Jan; 26(1):103-18. PubMed ID: 26680004
[TBL] [Abstract][Full Text] [Related]
14. Ten eleven translocation enzymes and 5-hydroxymethylation in mammalian development and cancer.
Kinney SR; Pradhan S
Adv Exp Med Biol; 2013; 754():57-79. PubMed ID: 22956496
[TBL] [Abstract][Full Text] [Related]
15. TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma.
Murata A; Baba Y; Ishimoto T; Miyake K; Kosumi K; Harada K; Kurashige J; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Yamamoto M; Oda S; Watanabe M; Nakao M; Baba H
Oncotarget; 2015 Sep; 6(27):23372-82. PubMed ID: 26093090
[TBL] [Abstract][Full Text] [Related]
16. Characterization of acute myeloid leukemia based on levels of global hydroxymethylation.
Kroeze LI; Aslanyan MG; van Rooij A; Koorenhof-Scheele TN; Massop M; Carell T; Boezeman JB; Marie JP; Halkes CJ; de Witte T; Huls G; Suciu S; Wevers RA; van der Reijden BA; Jansen JH;
Blood; 2014 Aug; 124(7):1110-8. PubMed ID: 24986689
[TBL] [Abstract][Full Text] [Related]
17. The role of 5-hydroxymethylcytosine in human cancer.
Pfeifer GP; Xiong W; Hahn MA; Jin SG
Cell Tissue Res; 2014 Jun; 356(3):631-41. PubMed ID: 24816989
[TBL] [Abstract][Full Text] [Related]
18. A validated quantitative liquid chromatography-tandem quadrupole mass spectrometry method for monitoring isotopologues to evaluate global modified cytosine ratios in genomic DNA.
Tsuji M; Matsunaga H; Jinno D; Tsukamoto H; Suzuki N; Tomioka Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():38-47. PubMed ID: 24568937
[TBL] [Abstract][Full Text] [Related]
19. Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior.
Szabó B; Németh K; Mészáros K; Szücs N; Czirják S; Reiniger L; Rajnai H; Krencz I; Karászi K; Krokker L; Patócs A; Butz H
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32232382
[TBL] [Abstract][Full Text] [Related]
20. 5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
Tomkova M; McClellan M; Kriaucionis S; Schuster-Boeckler B
Elife; 2016 May; 5():. PubMed ID: 27183007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
